Labiotech.eu

ADN Que sont les Biotechnologies 1213x418

News and Trends 20 Apr 2015

So, what is actually Biotech?

Biotechnology is a broad domain, which includes numerous areas such as healing, feeding and fueling the world. Historically-speaking, the biotech sector started in the 80s with the discovery of gene cloning. The first “Biotech” ever born was Genentech (contraction of Gene and Technology), founded in South San Francisco, which successfully produced human insulin in bacteria. The Organisation […]

April 20, 2015 - 4 minutesmins - By Nicolas Sainte-Foie

News and Trends 18 Apr 2015

Another Partnership between Immunocore and MedImmune against Skin Cancer

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases, and MedImmune, the global biologics research and development arm of AstraZeneca have just entered into a second effective collaboration for a potential skin cancer treatment. It concerns melanoma which is a form of skin cancer that accounts for less than five per cent of […]

April 18, 2015 - 2 minutesmins - By Julie Lellouche

TEVA Eagle Pharmaceuticals leukemia bendamustine

News and Trends 17 Apr 2015

Teva took the first step to get the approval of its new leukemia treatment

FDA accepted Teva Pharma’s New Drug Application (NDA) for a liquid bendamustine hydrochloride (HCl) rapid infusion product. The drug, developed with Eagle Pharmaceuticals is now waiting for the Prescription Drug User Fee Act (PDUFA), which is expected for December 2015. In the meantime, the Israeli company remains unstoppable after a great begining of the month on […]

April 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 17 Apr 2015

Merck Serono bets on Oncology with the appointment of Dr. Alise Reicin

Merck Serono appointed Dr. Alise Reicin as Senior Vice President, Head of Global Clinical Development. The appointment is yet another example of Merck’s clear interest in oncology and immunology, two fields in which Dr. Reicin expertised. Dr. Reicin will also bring extensive research and early/late clinical development expertise to Merck Serono. In her role as […]

April 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Apr 2015

Histalim, already 10 years committed to Histology

In the prestigious Fabre Museum of Montpelier (France), Thursday, April 9, 2015, Histalim organized for his birthday, an afternoon of table speeches around bioservices and also an evening with contemporary art exhibition and concert. Histalim, founded in June 2005, provides services around histology to different players in the pharmaceutical and medical industry and agri-food research. […]

April 16, 2015 - 5 minutesmins - By Cédric Brock

News and Trends 16 Apr 2015

The first-in-human Phase I trial for a treatment against glaucoma core

Isarna Therapeutics has initiated Phase I clinical trial with ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta (TGF-ß2) to treat advanced glaucoma. This first-in-human Phase I trial, conducted at the University Hospitals of Mainz and Tuebingen, Germany, is designed to evaluate the safety and long-term tolerability of ISTH0036 in patients with advanced glaucoma […]

April 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Apr 2015

Wilson Therapeutics on its way to cure Wilson disease

Wilson Therapeutics has closed a €37.4M Series B financing to advance its late-stage development program for Wilson’s disease. The company will present its ongoing Phase II trial of WTX101-201, the company’s treatment for this disease, at the upcoming 50th International Liver Congress 2015. Approximately 1 in 15000 people worldwide have Wilson Disease, a rare genetic disorder that prevents the […]

April 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Apr 2015

Bayer Healthcare invests €94 Million in its Hemophilia pipeline

Bayer HealthCare, a subgroup of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry. Yesterday, the company announced a €94M investment in its Berkeley (California) manufacturing site to build a product testing facility that will support the next generation of treatments for patients with hemophilia A. David […]

April 16, 2015 - 2 minutesmins - By Joachim Eeckhout

final sterilization proteins solution sanofi pasteur

News and Trends 16 Apr 2015

The challenge of terminal sterilization of Proteins

The production of biologicals is an important challenge for the industry. Today, very often, the only way to have a sterile final product is to, first, use sterile components and then, launch the production in a fully aseptic manufacturing facility. What if we could terminally sterilize the protein-based outcome once produced? More and more biologicals are brought to the market, […]

April 16, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 16 Apr 2015

flash4science, the life science private shopping club

Any scientist knows how expensive purchasing new equipment can be. However, one platform, flash4Science, in particular caught our attention. The company located in Germany has set itself an interesting challenge as it tries to combine life sciences and private shopping together. Two domains, which, on paper, seem completely incompatible! It is the world’s first biotech […]

April 16, 2015 - 2 minutesmins - By Alexandre Lowrey

News and Trends 15 Apr 2015

Synthetic bio: one single Grapefruit to produce one Million liters of Juice

The Austrian Centre of Industrial Biotechnology (acib), using synthetic biology technology, developed a new method to produce Nootkatone, an expensive grapefruit aroma. The biotechnological process uses cheap sugar as substrate for a “turbo-yeast”. The extremely expensive substance is used in soft drinks, pharmaceutical products or even as an insect repellent, and it is found only […]

April 15, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 15 Apr 2015

Heart Metabolics bargain with the FDA for a single Phase III

Heart Metabolics received an agreement letter from the FDA related to the company’s proposed phase III trial Special Protocol Assessment (SPA) request. The FDA has agreed to a single, randomized, pivotal Phase III trial of 350 patients evaluating perhexiline for the treatment of moderate-to-severe hypertrophic cardiomyopathy (HCM). The company, focused on the development of drugs […]

April 15, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

So, what is actually Biotech?

Another Partnership between Immunocore and MedImmune against Skin Cancer

Teva took the first step to get the approval of its new leukemia treatment

Merck Serono bets on Oncology with the appointment of Dr. Alise Reicin

Histalim, already 10 years committed to Histology

The first-in-human Phase I trial for a treatment against glaucoma core

Wilson Therapeutics on its way to cure Wilson disease

Bayer Healthcare invests €94 Million in its Hemophilia pipeline

The challenge of terminal sterilization of Proteins

flash4science, the life science private shopping club

Synthetic bio: one single Grapefruit to produce one Million liters of Juice

Heart Metabolics bargain with the FDA for a single Phase III

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!